Adrenocortical Hormones API Market Size is valued at USD 2.24 Bn in 2023 and is predicted to reach USD 3.55 Bn by the year 2031 at a 6.04% CAGR during the forecast period for 2024-2031.
Adrenocortical hormones, also referred to as corticosteroids or adrenal cortex hormones, are steroid hormones synthesized by the adrenal cortex, which is a component of the adrenal gland. This hormone is synthesized or extracted to be used as API (Active Pharmaceutical Ingredients) in medications that are designed to treat a variety of conditions related to inflammation, immune response, and metabolism. Adrenocortical hormones, when used as API, play a crucial role in the field of pharmaceuticals. They provide essential treatments for a variety of disorders that impact millions of people globally. Ongoing research and regulation are focused on developing and producing them while ensuring a balance between effectiveness and safety.
Adrenocortical hormone-active pharmaceutical ingredients are in high demand in the pharmaceutical industry because of the rising incidence of hormonal imbalances brought about by increased public knowledge of the problem and better diagnostic tools. The market demand for this adrenocortical hormones API is being driven by In addition, the demand for adrenocortical hormones is on the rise due to the fact that more people are able to access treatment alternatives due to rising healthcare spending and healthcare infrastructure expansion around the world. The demand for adrenocortical hormones API is being driven by the growing number of people who can afford healthcare services, which is a consequence of the healthcare industry’s expansion.
However, market growth is impeded by a stringent regulatory landscape and high costs. The COVID-19 pandemic brought up many issues for healthcare manufacturers, such as shaky marketplaces, falling consumer trust, and messed-up import/export processes. In addition, the adrenocortical hormones API market is being significantly influenced by research in pharmaceutical production and technical improvements; manufacturers and researchers are putting money into state-of-the-art technology and new methods, providing opportunities for market growth in the coming years.
The adrenocortical hormones API market is segmented based on type and application. Based on type, the market is segmented into dexamethasone series, betamethasone series, hydrocortisone series, and others. By application, the market is segmented into injectable drugs, oral drugs, external use drugs, and inhalation drugs.
The hydrocortisone series adrenocortical hormones API adrenocortical hormones API market is expected to hold a major global market share.. This is propelled by a growing number of dermatological disorders, such as eczema, psoriasis, and dermatitis, which require topical formulations of hydrocortisone, and the drug is essential in the treatment of adrenal insufficiency, which includes Addison’s disease and other similar disorders. More and more people are suffering from long-term health issues that necessitate the use of immunosuppressants and anti-inflammatory medications, which in turn drives the demand for hydrocortisone series. Growth in the prevalence of chronic health problems and an aging population suggests that the hydrocortisone series will be in high demand.
Injectable drugs are growing because of their quick onset of action and precise control over dosage. These advantages make them ideal for adrenocortical hormone API treatments, which require exact concentrations for optimal efficacy. These advantages are especially important in acute care settings where therapeutic effects must be felt immediately. The expansion and improvement of healthcare infrastructure around the world, particularly the availability of medical facilities and healthcare workers trained to inject patients, is another factor fueling the evolution of this industry.
The North American adrenocortical hormones API market is expected to record a largest market revenue share in the near future. This can be attributed to a well-established healthcare system that provides medical treatment to a large population and a high incidence of hormonal and endocrine diseases. In addition, Asia Pacific is estimated to grow rapidly in the global adrenocortical hormones API market because of a highly developed healthcare system, encourages the development of new pharmaceuticals, increases spending on healthcare, and a rising public and professional understanding of the significance of identifying and treating hormone abnormalities early in this region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 2.24 Bn |
|
Revenue Forecast In 2031 |
USD 3.55 Bn |
|
Growth Rate CAGR |
CAGR of 6.04% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, And End User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Sanofi, GlaxoSmithKline, Xianju Pharma, Teva, Piramal Pharma Solutions, Guangzhou Tosun Pharmaceutical, BCN Peptides, Guangdong VTR Bio-Tech Co., Ltd, Symbiotec Pharmalab, Sun Pharmaceutical, Cipla, Hovione, Shandong Xinhua Pharmaceutical Company Limited, Steroid SpA, Junye Pharmaceutical Co., Ltd., Avik Pharmaceutical, Tianjin Pacific Pharmaceutical Co., Ltd (TJPP), Shandong Sito Bio-technology CO., LTD., and Other Market Players |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Adrenocortical Hormones API Market Snapshot
Chapter 4. Global Adrenocortical Hormones API Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Dexamethasone Series
5.2.2. Betamethasone Series
5.2.3. Hydrocortisone Series
5.2.4. Others
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Injectable Drugs
6.2.2. Oral Drugs
6.2.3. For External Use Drugs
6.2.4. Inhalation Drugs
Chapter 7. Adrenocortical Hormones API Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.1.2. North America Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.1.3. North America Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.2. Europe
7.2.1. Europe Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.2.2. Europe Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.2.3. Europe Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.3.2. Asia-Pacific Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.3.3. Asia Pacific Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.4. Latin America
7.4.1. Latin America Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.4.2. Latin America Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.4.3. Latin America Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
7.5.2. Middle East & Africa Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
7.5.3. Middle East & Africa Adrenocortical Hormones API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Sanofi (France)
8.2.2. GlaxoSmithKline (U.K.)
8.2.3. Xianju Pharma (China)
8.2.4. Teva (Israel)
8.2.5. Piramal Pharma Solutions
8.2.6. Guangzhou Tosun Pharmaceutical
8.2.7. BCN Peptides
8.2.8. Guangdong VTR Bio-Tech Co., Ltd,
8.2.9. Symbiotec Pharmalab,
8.2.10. Sun Pharmaceutical,
8.2.11. Cipla,
8.2.12. Hovione,
8.2.13. Shandong Xinhua Pharmaceutical Company Limited,
8.2.14. Steroid SpA,
8.2.15. Junye Pharmaceutical Co., Ltd.,
8.2.16. Avik Pharmaceutical,
8.2.17. Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
8.2.18. Shandong Sito Bio-technology CO., LTD.
8.2.19. Other Market Players
Adrenocortical Hormones API Market By Type-
Adrenocortical Hormones API Market By Application-
Adrenocortical Hormones API Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
